Developed in conjunction with

September, 2015
SOM Biotech announces that its product development partnership...
September, 2015
SOM Biotech has just filed a new patent application for the treatment of Psoriasis, chronic and autoimmune disease that...

July, 2013

SOM has licensed to the biotech  ARGON Pharma  a new product with potential properties for the treatment of multiforme glioblastoma. The compound was discovered by SOM as SOM0777.